|
| | 102ND GENERAL ASSEMBLY
State of Illinois
2021 and 2022 SB0300 Introduced 2/19/2021, by Sen. Jason A. Barickman SYNOPSIS AS INTRODUCED: |
| 740 ILCS 14/10 | | 740 ILCS 14/15 | | 740 ILCS 14/20 | | 740 ILCS 14/21 new | | 740 ILCS 14/22 new | | 740 ILCS 14/25 | |
|
Amends the Biometric Information Privacy Act. Changes the definitions of "biometric information" and "written consent". Provides that a right of action shall be commenced within one year after the cause of action accrued, if, prior to initiating any action against a private entity, the aggrieved person provides a private entity 30 days' written notice identifying the specific provisions of the Act the aggrieved person alleges have been or are being violated. Provides that if within the 30 days the private entity cures the noticed violation as to the person providing notice and provides the person providing notice an express written statement that the violations have been cured and that no further violations shall occur, no action for damages of any kind may be initiated by the person providing notice against the private entity. Provides that if a private entity continues to violate the Act in breach of the express written statement, the aggrieved person may initiate an action against the private entity to enforce the written statement and may pursue statutory damages for each breach of the express written statement, as well as any other violation of the Act that postdates the written statement. Provides that a prevailing party may recover: against a private entity that negligently violates the Act, actual damages (rather than liquidated damages of $1,000 or actual damages); or against a private entity that willfully (rather than intentionally or recklessly) violates the Act, actual damages plus liquidated damages up to the amount of actual damages (rather than liquidated damages of $5,000 or actual damages). Add language governing: when certain claims accrue; limitations regarding the collection and use of biometric information to detect or contain the spread of COVID-19; and construction of the Act. Makes other changes.
|
| |
| | A BILL FOR |
|
|
| | SB0300 | | LRB102 13254 LNS 18598 b |
|
|
1 | | AN ACT concerning civil law.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Biometric Information Privacy Act is |
5 | | amended by changing Sections 10, 15, 20, and 25 and by adding |
6 | | Sections 21 and 22 as follows: |
7 | | (740 ILCS 14/10)
|
8 | | Sec. 10. Definitions. In this Act: |
9 | | "Biometric identifier" means a retina or iris scan, |
10 | | fingerprint, voiceprint, or scan of hand or face geometry. |
11 | | Biometric identifiers do not include writing samples, written |
12 | | signatures, photographs, human biological samples used for |
13 | | valid scientific testing or screening, demographic data, |
14 | | tattoo descriptions, or physical descriptions such as height, |
15 | | weight, hair color, or eye color. Biometric identifiers do not |
16 | | include donated organs, tissues, or parts as defined in the |
17 | | Illinois Anatomical Gift Act or blood or serum stored on |
18 | | behalf of recipients or potential recipients of living or |
19 | | cadaveric transplants and obtained or stored by a federally |
20 | | designated organ procurement agency. Biometric identifiers do |
21 | | not include biological materials regulated under the Genetic |
22 | | Information Privacy Act. Biometric identifiers do not include |
23 | | information captured from a patient in a health care setting |
|
| | SB0300 | - 2 - | LRB102 13254 LNS 18598 b |
|
|
1 | | or information collected, used, or stored for health care |
2 | | treatment, payment, or operations under the federal Health |
3 | | Insurance Portability and Accountability Act of 1996. |
4 | | Biometric identifiers do not include an X-ray, roentgen |
5 | | process, computed tomography, MRI, PET scan, mammography, or |
6 | | other image or film of the human anatomy used to diagnose, |
7 | | prognose, or treat an illness or other medical condition or to |
8 | | further validate scientific testing or screening. |
9 | | "Biometric information" means any information, regardless |
10 | | of how it is captured, converted, stored, or shared, based on |
11 | | an individual's biometric identifier used to identify an |
12 | | individual. Biometric information does not include information |
13 | | derived from items or procedures excluded under the definition |
14 | | of biometric identifiers. Biometric information does not |
15 | | include information that cannot be used to recreate the |
16 | | original biometric identifier. |
17 | | "Confidential and sensitive information" means personal |
18 | | information that can be used to uniquely identify an |
19 | | individual or an individual's account or property. Examples of |
20 | | confidential and sensitive information include, but are not |
21 | | limited to, a genetic marker, genetic testing information, a |
22 | | unique identifier number to locate an account or property, an |
23 | | account number, a PIN number, a pass code, a driver's license |
24 | | number, or a social security number. |
25 | | "Private entity" means any individual, partnership, |
26 | | corporation, limited liability company, association, or other |
|
| | SB0300 | - 3 - | LRB102 13254 LNS 18598 b |
|
|
1 | | group, however organized.
A private entity does not include a |
2 | | State or local governmental government agency. A private |
3 | | entity does not include any court of Illinois, a clerk of the |
4 | | court, or a judge or justice thereof. |
5 | | "Written release" means informed written consent or, in |
6 | | the context of employment, a release executed by an employee |
7 | | as a condition of employment. Written consent includes consent |
8 | | obtained by electronic means.
|
9 | | (Source: P.A. 95-994, eff. 10-3-08.) |
10 | | (740 ILCS 14/15)
|
11 | | Sec. 15. Retention; collection; disclosure; destruction. |
12 | | (a) A private entity in possession of biometric |
13 | | identifiers or biometric information must develop a written |
14 | | policy, made available to the person from whom biometric |
15 | | identifiers or biometric information is to be or was collected |
16 | | public , establishing a retention schedule and guidelines for |
17 | | permanently destroying biometric identifiers and biometric |
18 | | information when the initial purpose for collecting or |
19 | | obtaining such identifiers or information has been satisfied |
20 | | or within 3 years of the individual's last interaction with |
21 | | the private entity, whichever occurs first. Absent a valid |
22 | | order, warrant , or subpoena issued by a court of competent |
23 | | jurisdiction or a local, State, or federal governmental |
24 | | agency, or as otherwise required by law , a private entity in |
25 | | possession of biometric identifiers or biometric information |
|
| | SB0300 | - 4 - | LRB102 13254 LNS 18598 b |
|
|
1 | | must comply with its established retention schedule and |
2 | | destruction guidelines. |
3 | | (b) No private entity may collect, capture, purchase, or |
4 | | receive through trade , or otherwise obtain a person's or a |
5 | | customer's biometric identifier or biometric information, |
6 | | unless it first: |
7 | | (1) informs the subject or the subject's legally |
8 | | authorized representative in writing that a biometric |
9 | | identifier or biometric information is being collected or |
10 | | stored; |
11 | | (2) informs the subject or the subject's legally |
12 | | authorized representative in writing of the specific |
13 | | purpose and length of term for which a biometric |
14 | | identifier or biometric information is being collected, |
15 | | stored, and used; and |
16 | | (3) receives a written consent release executed by the |
17 | | subject of the biometric identifier or biometric |
18 | | information or the subject's legally authorized |
19 | | representative.
|
20 | | (c) No private entity in possession of a biometric |
21 | | identifier or biometric information may sell, lease, trade, or |
22 | | otherwise profit from a person's or a customer's biometric |
23 | | identifier or biometric information. |
24 | | (d) No private entity in possession of a biometric |
25 | | identifier or biometric information may disclose or , |
26 | | redisclose , or otherwise disseminate a person's or a |
|
| | SB0300 | - 5 - | LRB102 13254 LNS 18598 b |
|
|
1 | | customer's biometric identifier or biometric information
|
2 | | unless: |
3 | | (1) the subject of the biometric identifier or
|
4 | | biometric information or the subject's legally authorized
|
5 | | representative provides written consent consents to the |
6 | | disclosure or redisclosure; |
7 | | (2) the disclosure or redisclosure completes a |
8 | | financial transaction requested or authorized by the |
9 | | subject of the biometric identifier or the biometric |
10 | | information or the subject's legally authorized |
11 | | representative; |
12 | | (3) the disclosure or redisclosure is required by |
13 | | local, State , or federal governmental agency, or as |
14 | | otherwise required by law or municipal ordinance ; or |
15 | | (4) the disclosure is required pursuant to a valid |
16 | | order, warrant , or subpoena issued by a court of competent |
17 | | jurisdiction or a local, State, or federal governmental |
18 | | agency, or as otherwise required by law .
|
19 | | (e) A private entity in possession of a biometric |
20 | | identifier or biometric information shall: |
21 | | (1) store, transmit, and protect from disclosure all |
22 | | biometric identifiers and biometric information using the |
23 | | reasonable standard of care within the private entity's |
24 | | industry; and
|
25 | | (2) store, transmit, and protect from disclosure all |
26 | | biometric identifiers and biometric information in a |
|
| | SB0300 | - 6 - | LRB102 13254 LNS 18598 b |
|
|
1 | | manner that is the same as or more protective than the |
2 | | manner in which the private entity stores, transmits, and |
3 | | protects other confidential and sensitive information.
|
4 | | (Source: P.A. 95-994, eff. 10-3-08.) |
5 | | (740 ILCS 14/20)
|
6 | | Sec. 20. Right of action. Any person aggrieved by a |
7 | | violation of this Act shall have a right of action in a State |
8 | | circuit court or as a supplemental claim in federal district |
9 | | court against an offending party that shall be commenced |
10 | | within one year next after the cause of action accrued, if, |
11 | | prior to initiating any action against a private entity, the |
12 | | aggrieved person provides a private entity 30 days' written |
13 | | notice identifying the specific provisions of this Act the |
14 | | aggrieved person alleges have been or are being violated. If |
15 | | within the 30 days the private entity cures the noticed |
16 | | violation as to the person providing notice and provides the |
17 | | person providing notice an express written statement that the |
18 | | violations have been cured and that no further violations |
19 | | shall occur, no action for damages of any kind may be initiated |
20 | | by the person providing notice against the private entity. If |
21 | | a private entity continues to violate this Act in breach of the |
22 | | express written statement provided under this Section, the |
23 | | aggrieved person may initiate an action against the private |
24 | | entity to enforce the written statement and may pursue |
25 | | statutory damages for each breach of the express written |
|
| | SB0300 | - 7 - | LRB102 13254 LNS 18598 b |
|
|
1 | | statement, as well as any other violation of the Act that |
2 | | postdates the written statement . A prevailing party in any |
3 | | such action may recover for each violation : |
4 | | (1) against a private entity that negligently violates |
5 | | a provision of this Act, liquidated damages of $1,000 or |
6 | | actual damages , whichever is greater ; |
7 | | (2) against a private entity that willfully |
8 | | intentionally or recklessly violates a provision of this |
9 | | Act, actual damages plus liquidated damages up to the |
10 | | amount of actual damages of $5,000 or actual damages, |
11 | | whichever is greater ; |
12 | | (3) reasonable attorneys' fees and costs, including |
13 | | expert witness fees and other litigation expenses; and |
14 | | (4) other relief, including an injunction, as the |
15 | | State or federal court may deem appropriate.
|
16 | | As used in this Section, "cure" means to provide the |
17 | | disclosures or obtain the consent required by this Act within |
18 | | 30 days of the receipt of the written notice described in this |
19 | | Section or to, within that same period, otherwise demonstrate |
20 | | compliance with this Act. |
21 | | (Source: P.A. 95-994, eff. 10-3-08.) |
22 | | (740 ILCS 14/21 new) |
23 | | Sec. 21. Accrual. A claim accrues under subsection (b) of |
24 | | Section 15 upon a person's first use of the technology that the |
25 | | person claims collected the person's biometric identifier or |
|
| | SB0300 | - 8 - | LRB102 13254 LNS 18598 b |
|
|
1 | | biometric information. A claim accrues under subsection (d) of |
2 | | Section 15 upon the first disclosure or redisclosure of the |
3 | | person's biometric identifier or biometric information. |
4 | | (740 ILCS 14/22 new) |
5 | | Sec. 22. COVID-19 limitation. Notwithstanding any |
6 | | provision of this Act, a private entity shall not be subject to |
7 | | any enforcement proceeding or liability under any provision of |
8 | | this Act if the private entity collected, obtained, or |
9 | | retained the biometric identifier or biometric information as |
10 | | part of its efforts to detect or contain the spread of |
11 | | COVID-19. |
12 | | (740 ILCS 14/25)
|
13 | | Sec. 25. Construction. |
14 | | (a) Nothing in this Act shall be construed to impact the |
15 | | admission or discovery of biometric identifiers and biometric |
16 | | information in any action of any kind in any court, or before |
17 | | any tribunal, board, agency, or person. |
18 | | (b) Nothing in this Act shall be construed to conflict |
19 | | with the X-Ray Retention Act, the federal Health Insurance |
20 | | Portability and Accountability Act of 1996 and the rules |
21 | | promulgated under either Act. |
22 | | (c) Nothing in this Act shall be deemed to apply in any |
23 | | manner to a financial institution or an affiliate of a |
24 | | financial institution that is subject to Title V of the |
|
| | SB0300 | - 9 - | LRB102 13254 LNS 18598 b |
|
|
1 | | federal Gramm-Leach-Bliley Act of 1999 and the rules |
2 | | promulgated thereunder. |
3 | | (d) Nothing in this Act shall be construed to conflict |
4 | | with the Private Detective, Private Alarm, Private Security, |
5 | | Fingerprint Vendor, and Locksmith Act of 2004 and the rules |
6 | | promulgated thereunder. |
7 | | (e) Nothing in this Act shall be construed to apply to a |
8 | | contractor, subcontractor, or agent of a State or federal |
9 | | agency or local unit of government when working for that State |
10 | | or federal agency or local unit of government.
|
11 | | (Source: P.A. 95-994, eff. 10-3-08.)
|